A review on hyponatremia associated with SSRIs, reboxetine and venlafaxine

References

• Olfson M, Klerman GL. Trends in the prescription of antidepressants by office-based psychiatrists. Am J Psychiatry 1993; 150(4)571–7
   PubMed Web of Science ®Google Scholar
• Baldwin DS. Unmet needs in the pharmacological management of depression. Hum Psychopharmacol 2001; 16(S2)S93–9
   Google Scholar
• Geretsegger C, Stuppaeck CH, Mair M, et al. Multicenter double blind study of paroxetine and amitriptyline in elderly depressed inpatients. Psychopharmacology (Berlin) 1995; 119(3)277–81
   Google Scholar
• Thase ME, Sloan DME. Venlafaxine. Textbook of Psychopharmacology, AF Schatzberg, CB Nemeroff. American Psychiatric Publishing, Arlington, VA 2004; 349
   Google Scholar
• Schweizer E, Weise C, Clary C, et al. Placebo-controlled trial of venlafaxine for the treatment of major depression. J Clin Psychopharmacol 1991; 11(4)233–6
   PubMed Web of Science ®Google Scholar
• Sharma H, Pompei P. Antidepressant-induced hyponatraemia in the aged. Avoidance and management strategies. Drugs Aging 1996; 8(6)430–5
   Google Scholar
• Spigset O, Hedenmalm K. Hyponatraemia and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by psychotropic drugs. Drug Saf 1995; 12(3)209–25
   Google Scholar
• Singer GS, Brenner BM. Fluid and electrolyte disturbances. Harrison′s principles of internal medicine, AS Fauci, E Braunwald, KJ Isselbacher, JD Wilson, JB Martin, DL Kasper, et al. McGraw-Hill, Health Professions Division, New York 1998
   Google Scholar
• Adrogue HJ, Madias NE. Hyponatremia. New Engl J Med 2000; 342(21)1581–9
   PubMed Web of Science ®Google Scholar
• Chung HM, Kluge R, Schrier RW, Anderson RJ. Clinical assessment of extracellular fluid volume in hyponatremia. Am J Med 1987; 83(5)905–8
   PubMed Web of Science ®Google Scholar
• Baylis PH. The syndrome of inappropriate antidiuretic hormone secretion. Int J Biochem Cell Biol 2003; 35(11)1495–9
   Google Scholar
• Miller M, Hecker MS, Friedlander DA, Carter JM. Apparent idiopathic hyponatremia in an ambulatory geriatric population. J Am Geriatr Soc 1996; 44(4)404–8
   Google Scholar
• Palmer BF, Gates JR, Lader M. Causes and management of hyponatremia. Ann Pharmacother 2003; 37(11)1694–702
   PubMed Web of Science ®Google Scholar
• Miller, M. Hyponatremia: age-related risk factors and therapy decisions. Geriatrics 1998;53(7):32–8, 41.
   PubMedGoogle Scholar
• Boczkowski JA, Levine EG. Pseudodepression in hyponatremia. J Nerv Ment Dis 1991; 179(8)508–10
   Google Scholar
• Arieff AI, Llach F, Massry SG. Neurological manifestations and morbidity of hyponatremia: Correlation with brain water and electrolytes. Medicine (Baltimore) 1976; 55(2)121–9
   PubMedGoogle Scholar
• Hirshberg B, Ben-Yehuda A. The syndrome of inappropriate antidiuretic hormone secretion in the elderly. Am J Med 1997; 103(4)270–3
   Web of Science ®Google Scholar
• Sunderam SG, Mankikar GD. Hyponatraemia in the elderly. Age Ageing 1983; 12(1)77–80
   PubMed Web of Science ®Google Scholar
• Rehman HU, Masson EA. Neuroendocrinology of ageing. Age Ageing 2001; 30(4)279–87
   Google Scholar
• Turnheim K. When drug therapy gets old: Pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol 2003; 38(8)843–53
   PubMed Web of Science ®Google Scholar
• Goldman MB, Luchins DJ, Robertson GL. Mechanisms of altered water metabolism in psychotic patients with polydipsia and hyponatremia. New Engl J Med 1988; 318(7)397–403
   Google Scholar
• Illowsky BP, Kirch DG. Polydipsia and hyponatremia in psychiatric patients. Am J Psychiatry 1988; 145(6)675–83
   PubMed Web of Science ®Google Scholar
• Emsley RA, van der MH, Aalbers C, Taljaard JJ. Inappropriate antidiuretic state in long-term psychiatric inpatients. S Afr Med J 1990; 77(6)307–8
   Google Scholar
• Kramer DS, Drake ME, Jr. Acute psychosis, polydipsia, and inappropriate secretion of antidiuretic hormone. Am J Med 1983; 75(4)712–4
   Google Scholar
• Riggs AT, Dysken MW, Kim SW, Opsahl JA. A review of disorders of water homeostasis in psychiatric patients. Psychosomatics 1991; 32(2)133–48
   PubMed Web of Science ®Google Scholar
• Delva NJ, Crammer JL. Polydipsia in chronic psychiatric patients. Body weight and plasma sodium. Br J Psychiatry 1988; 152: 242–5
   PubMed Web of Science ®Google Scholar
• Kirch DG, Bigelow LB, Weinberger DR, et al. Polydipsia and chronic hyponatremia in schizophrenic inpatients. J Clin Psychiatry 1985; 46(5)179–81
   Google Scholar
• van Londen L, Goekoop JG, van Kempen GM, et al. Plasma levels of arginine vasopressin elevated in patients with major depression. Neuropsychopharmacology 1997; 17(4)284–92
   Web of Science ®Google Scholar
• Siegler EL, Tamres D, Berlin JA, et al. Risk factors for the development of hyponatremia in psychiatric inpatients. Arch Intern Med 1995; 155(9)953–7
   PubMed Web of Science ®Google Scholar
• Madhusoodanan S, Bogunovic OJ, Moise D, et al. Hyponatraemia associated with psychotropic medications. A review of the literature and spontaneous reports. Adverse Drug React Toxicol Rev 2002; 21(1–2)17–29
   Google Scholar
• Liskin B, Walsh BT, Roose SP, Jackson W. Imipramine-induced inappropriate ADH secretion. J Clin Psychopharmacol 1984; 4(3)146–7
   Google Scholar
• Abdelrahman N, Kleinman Y, Rund D, Da'as N. Hyponatremia associated with the initiation of reboxetine therapy. Eur J Clin Pharmacol 2003; 59(2)177
   Google Scholar
• Ranieri P, Franzoni S, Trabucchi M. Reboxetine and hyponatremia. New Engl J Med 2000; 342(3)215–6
   Google Scholar
• Sand PG, Atzinger AK, Buwe A. SNRI and hyponatremia. Int J Geriatr Psychiatry 2002; 17(5)491–2
   Google Scholar
• Chan TY. Drug-induced syndrome of inappropriate antidiuretic hormone secretion. Causes, diagnosis and management. Drugs Aging 1997; 11(1)27–44
   Google Scholar
• Degner D, Grohmann R, Kropp S, et al. Severe adverse drug reactions of antidepressants: Results of the German multicenter drug surveillance program AMSP. Pharmacopsychiatry 2004; 37(Suppl 1)S39–45
   PubMedGoogle Scholar
• Liu BA, Mittmann N, Knowles SR, Shear NH. Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: A review of spontaneous reports. Cam Med Ass J 1996; 155(5)519–27
   PubMed Web of Science ®Google Scholar
• Woo MH, Smythe MA. Association of SIADH with selective serotonin reuptake inhibitors. Ann Pharmacother 1997; 31(1)108–10
   Google Scholar
• Kirby D, Harrigan S, Ames D. Hyponatraemia in elderly psychiatric patients treated with selective serotonin reuptake inhibitors and venlafaxine: A retrospective controlled study in an inpatient unit. Int J Geriatr Psychiatry 2002; 17(3)231–7
   Web of Science ®Google Scholar
• AF Schatzberg, Nemeroff, CB, editors. The American Psychiatric Publishing textbook of psychopharmacology. Arlington, VA: American Psychiatric Publishing; 2004.
   Google Scholar
• Berzewski H, Van MM, Gagiano CA. Efficacy and tolerability of reboxetine compared with imipramine in a double-blind study in patients suffering from major depressive offsodes. Eur Neuropsychopharmacol 1997; 7(Suppl 1)S37–47
   PubMedGoogle Scholar
• Artigas F, Nutt DJ, Shelton R. Mechanism of action of antidepressants. Psychopharmacol Bull 2002; 36(Suppl 2)123–32
   Google Scholar
• Owens MJ, Morgan WN, Plott SJ, Nemeroff CB. Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J Pharmacol Exp Ther 1997; 283(3)1305–22
   PubMed Web of Science ®Google Scholar
• Roxanas MG. Mirtazapine-induced hyponatraemia. Med J Aust 2003; 179(8)453–4
   Google Scholar
• Pillans PI, Coulter DM. Fluoxetine and hyponatraemia – A potential hazard in the elderly. NZ Med J 1994; 107(973)85–6
   Google Scholar
• Bouman WP, Pinner G, Johnson H. Incidence of selective serotonin reuptake inhibitor (SSRI) induced hyponatraemia due to the syndrome of inappropriate antidiuretic hormone (SIADH) secretion in the elderly. Int J Geriatr Psychiatry 1998; 13(1)12–5
   PubMed Web of Science ®Google Scholar
• Movig KL, Leufkens HG, Lenderink AW, et al. Association between antidepressant drug use and hyponatraemia: A case-control study. Br J Clin Pharmacol 2002; 53(4)363–9
   PubMed Web of Science ®Google Scholar
• Catalano MC, Catalano G, Kanfer SN, et al. The effect of sertraline on routine blood chemistry values. Clin Neuropharmacol 2000; 23(5)267–70
   Google Scholar
• Critchlow S. Hynonatremia in elderly psychiatric inpatients. Int J Geriatr Psychiatry 1998; 13(11)816–8
   Google Scholar
• Strachan J, Shepherd J. Hyponatraemia associated with the use of selective serotonin re-uptake inhibitors. Aust NZ J Psychiatry 1998; 32(2)295–8
   PubMed Web of Science ®Google Scholar
• Wilkinson TJ, Begg EJ, Winter AC, Sainsbury R. Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people. Br J Clin Pharmacol 1999; 47(2)211–7
   Google Scholar
• Fabian TJ, Amico JA, Kroboth PD, et al. Paroxetine-induced hyponatremia in older adults: A 12–week prospective study. Arch Intern Med 2004; 164(3)327–32
   Google Scholar
• Marar IE, Towers AL, Mulsant BH, et al. Effect of paroxetine on plasma vasopressin and water load testing in elderly individuals. J Geriatr Psychiatry Neurol 2000; 13(4)212–6
   Google Scholar
• Spigset O, Mjorndal T. The effect of fluvoxamine on serum prolactin and serum sodium concentrations: Relation to platelet 5-HT2A receptor status. J Clin Psychopharmacol 1997; 17(4)292–7
   PubMedGoogle Scholar
• Spigset O, Wilhelmsson C, Mjorndal T, Eriksson S. Low serum sodium concentrations during treatment with citalopram in elderly patients: Relationship to serum citalopram levels and to platelet serotonin 5-HT2A receptor status. J Clin Psychopharmacol 2000; 20(5)582–4
   PubMed Web of Science ®Google Scholar
• Stedman CA, Begg EJ, Kennedy MA, et al. Cytochrome P450 2D6 genotype does not predict SSRI (fluoxetine or paroxetine) induced hyponatraemia. Hum Psychopharmacol 2002; 17(4)187–90
   PubMed Web of Science ®Google Scholar
• Kirby D, Ames D. Hyponatraemia and selective serotonin re-uptake inhibitors in elderly patients. Int J Geriatr Psychiatry 2001; 16(5)484–93
   PubMed Web of Science ®Google Scholar
• Hwang AS, Magraw RM. Syndrome of inappropriate secretion of antidiuretic hormone due to fluoxetine. Am J Psychiatry 1989; 146(3)399
   Google Scholar
• Blacksten JV, Birt JA. Syndrome of inappropriate secretion of antidiuretic hormone secondary to fluoxetine. Ann Pharmacother 1993; 27(6)723–4
   Google Scholar
• Jackson C, Carson W, Markowitz J, Mintzer J. SIADH associated with fluoxetine and sertraline therapy. Am J Psychiatry 1995; 152(5)809–10
   Google Scholar
• ten Holt WL, van Iperen CE, Schrijver G, Bartelink AK. Severe hyponatremia during therapy with fluoxetine. Arch Intern Med 1996; 156(6)681–2
   Google Scholar
• Druckenbrod R, Mulsant BH. Fluoxetine-induced syndrome of inappropriate antidiuretic hormone secretion: A geriatric case report and a review of the literature. J Geriatr Psychiatry Neurol 1994; 7(4)254–6
   Google Scholar
• Arinzon ZH, Lehman YA, Fidelman ZG, Krasnyansky II. Delayed recurrent SIADH associated with SSRIs. Ann Pharmacother 2002; 36(7–8)1175–7
   Web of Science ®Google Scholar
• Baliga RR, McHardy KC. Syndrome of inappropriate antidiuretic hormone secretion due to fluvoxamine therapy. Br J Clin Pract 1993; 47(2)62–3
   Google Scholar
• Ball CJ. Fluvoxamine and SIADH. Br J Clin Pract 1993; 47(4)227
   Google Scholar
• Arinzon ZH, Lehman YA, Fidelman ZG, Krasnyansky II. Delayed recurrent SIADH associated with SSRIs. Ann Pharmacother 2002; 36(7–8)1175–7
   Web of Science ®Google Scholar
• Leung VP, Chiu HF, Lam LC. Hyponatremia associated with paroxetine. Pharmacopsychiatry 1998; 31(1)32–4
   PubMed Web of Science ®Google Scholar
• Rosner MH. Severe hyponatremia associated with the combined use of thiazide diuretics and selective serotonin reuptake inhibitors. Am J Med Sci 2004; 327(2)109–11
   Google Scholar
• Schouten WE, Sepers JM. Hyponatraemia associated with the use of a selective serotonin-reuptake inhibitor in an older patient. Age Ageing 2001; 30(1)94
   Google Scholar
• Crews JR, Potts NL, Schreiber J, Lipper S. Hyponatremia in a patient treated with sertraline. Am J Psychiatry 1993; 150(10)1564
   Google Scholar
• Goldstein L, Barker M, Segall F, et al. Seizure and transient SIADH associated with sertraline. Am J Psychiatry 1996; 153(5)732
   Google Scholar
• Kessler J, Samuels SC. Sertraline and hyponatremia. New Engl J Med 1996; 335(7)524
   Google Scholar
• Leung M, Remick R. Sertraline-associated hyponatremia. Can J Psychiatry 1995; 40(8)497–8
   Google Scholar
• Barclay TS, Lee AJ. Citalopram-associated SIADH. Ann Pharmacother 2002; 36(10)1558–63
   Google Scholar
• Fisher A, Davis M, Croft-Baker J, et al. Citalopram-induced severe hyponatraemia with coma and seizure. Case report with literature and spontaneous reports review. Adverse Drug React Toxicol Rev 2002; 21(4)179–87
   Google Scholar
• Flores G, Perez-Patrigeon S, Cobos-Ayala C, Vergara J. Severe symptomatic hyponatremia during citalopram therapy – A case report. BMC Nephrol 2004; 5(1)2
   Google Scholar
• Bourgeois JA, Babine SE, Bahadur N. A case of SIADH and hyponatremia associated with citalopram. Psychosomatics 2002; 43(3)241–2
   Google Scholar
• Gupta AK, Saravay SM. Venlafaxine-induced hyponatremia. J Clin Psychopharmacol 1997; 17(3)223–5
   Google Scholar
• Masood GR, Karki SD, Patterson WR. Hyponatremia with venlafaxine. Ann Pharmacother 1998; 32(1)49–51
   Google Scholar
• Ranieri P, Franzoni S, Rozzini R, Trabucchi M. Venlafaxine-induced reset osmostat syndrome: Case of a 79-year-old depressed woman. J Geriatr Psychiatry Neurol 1997; 10(2)75–8
   Google Scholar
• Meynaar IA, Peeters AJ, Mulder AH, Ottervanger JP. Syndrome of inappropriate ADH secretion attributed to the serotonin re-uptake inhibitors, venlafaxine and paroxetine. Neth J Med 1997; 50(6)243–5
   Google Scholar
• Catalano G, Kanfer SN, Catalano MC, Alberts VA. The role of sertraline in a patient with recurrent hyponatremia. Gen Hosp Psychiatry 1996; 18(4)278–83
   Google Scholar
• Spigset O, Mjorndal T. The effect of fluvoxamine on serum prolactin and serum sodium concentrations: Relation to platelet 5-HT2A receptor status. J Clin Psychopharmacol 1997; 17(4)292–7
   PubMedGoogle Scholar
• Kirchner V, Silver LE, Kelly CA. Selective serotonin reuptake inhibitors and hyponatraemia: Review and proposed mechanisms in the elderly. J Psychopharmacol 1998; 12(4)396–400
   Web of Science ®Google Scholar
• Spigset O. Adverse reactions of selective serotonin reuptake inhibitors: Reports from a spontaneous reporting system. Drug Saf 1999; 20(3)277–87
   PubMedGoogle Scholar
• Topliss D, Isaacs D, Lander C, et al. Hyponatremia with SSRIs. Aust Drug Reactions Bull 2004; 22(3)10
   Google Scholar
• Flint AJ, Crosby J, Genik JL. Recurrent hyponatremia associated with fluoxetine and paroxetine. Am J Psychiatry 1996; 153(1)134
   Google Scholar
• Raphael K, Tokeshi J. Hyponatremia associated with sertraline and fluoxetine: a case report. Hawaii Med J 2002; 61(3)46–7
   PubMedGoogle Scholar
• Egger, C, Stuppaeck, CH. Electrolyte disturbances due to dual antidepressants. In: International Meeting on: Pharmacovigiliance in Psychiatry, Therapeutic Drug Monitoring and Pharmacogenetics of Psychotropic Drugs. 58. 2004. LausanneSwitzerland: University of Lausanne Department of Psychiatry (DP-CHUV).
   Google Scholar
• Doshi D, Borison R. Association of transient SIADH with sertraline. Am J Psychiatry 1994; 151(5)779–80
   Google Scholar
• Staab JP, Yerkes SA, Cheney EM, Clayton AH. Transient SIADH associated with fluoxetine. Am J Psychiatry 1990; 147(11)1569–70
   Google Scholar
• Bell C, Anderson D. SSRI-induced hyponatraemia. Int J Geriatr Psychiatry 1998; 13(2)128
   Google Scholar
• Raap DK, Van de Kar LD. Selective serotonin reuptake inhibitors and neuroendocrine function. Life Sci 1999; 65(12)1217–35
   Google Scholar
• Jorgensen H, Knigge U, Kjaer A, Warberg J. Serotonergic involvement in stress-induced vasopressin and oxytocin secretion. Eur J Endocrinol 2002; 147(6)815–24
   PubMed Web of Science ®Google Scholar
• Saydoff JA, Rittenhouse PA, Carnes M, et al. Neuroendocrine and cardiovascular effects of serotonin: Selective role of brain angiotensin on vasopressin. Am J Physiol 1996; 270(3 Pt 1)E513–21
   Google Scholar
• Inoue K, Tadai T, Kamimura H, et al. The syndrome of self-induced water intoxication in psychiatric patients. Folia Psychiatr Neurol Jpn 1985; 39(2)121–7
   Google Scholar
• Brownfield MS, Greathouse J, Lorens SA, et al. Neuropharmacological characterization of serotoninergic stimulation of vasopressin secretion in conscious rats. Neuroendocrinology 1988; 47(4)277–83
   PubMed Web of Science ®Google Scholar
• Knigge U, Willems E, Kjaer A, et al. Histaminergic and catecholaminergic interactions in the central regulation of vasopressin and oxytocin secretion. Endocrinology 1999; 140(8)3713–9
   PubMed Web of Science ®Google Scholar
• Fattinger K, Roos M, Vergeres P, et al. Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine. Br J Clin Pharmacol 2000; 49(2)158–67
   PubMed Web of Science ®Google Scholar
• Strain JJ, Caliendo G, Alexis JD, et al. Cardiac drug and psychotropic drug interactions: significance and recommendations. Gen Hosp Psychiatry 1999; 21(6)408–29
   Google Scholar
• Chua TP, Vong SK. Hyponatraemia associated with paroxetine. Br Med J 1993; 306(6870)143
   Google Scholar
• Corrington KA, Gatlin CC, Fields KB. A case of SSRI-induced hyponatremia. J Am Board Fam Pract 2002; 15(1)63–5
   Google Scholar
• Wee R, Lim WK. Selective serotonin re-uptake inhibitors (SSRIs) and hyponatraemia in the elderly. Int J Geriatr Psychiatry 2004; 19(6)590–1
   Google Scholar
• Moses AM, Streeten DHP. Disorders of the neurohypophysis. Harrison′s principles of internal medicine, AS Fauci, E Braunwald, KJ Isselbacher, JD Wilson, JB Martin, DL Kasper, et al. McGraw-Hill, Health Professions Division, New York 1998
   Google Scholar
• Sterns RH, Riggs JE, Schochet SS, Jr. Osmotic demyelination syndrome following correction of hyponatremia. New Engl J Med 1986; 314(24)1535–42
   Google Scholar
• Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Am Med Assoc 2002;288(23):2981–97.
   PubMed Web of Science ®Google Scholar
• Taylor WD, McQuoid DR, Krishnan KR. Medical comorbidity in late-life depression. Int J Geriatr Psychiatry 2004; 19(10)935–43
   Google Scholar